CELL THERAPY ADVANCES - SEVERAL HURDLES YET REMAIN

Cell therapies are a promising treatment for degenerative diseases that are prevalent in an aging population such as Parkinson’s disease. The following article - Cell Therapy Advances - Several Hurdles Remain is about the current status and success of cell therapy, a transformative technology in biohealth contributing to the "personalization" of healthcare.  The author is Derrick Rancourt, a professor - a knowledge seeker, at the University of Calgary and a mentor of student entrepreneurs.

Alberta became the third jurisdiction in Canada, after Ontario and Quebec, to allow cell therapy in the treatment of some forms of cancer, namely lymphocytic cancers.  Cell-based therapy (CBT) is proving more effective than conventional cancer therapeutic approaches. The approach has proved successful but more work remains to be done to improve the treatment’s success and reduce the cost. FOR MORE.

KEI's communications are about science and society, vision and leadership. Articles are selected to make you think and as such can from time to time be provocative. 

We seek out and share stories about emerging technologies with disruptive potential, disruptive in the sense that they have the potential to transform or displace an established industry or profession. To realize that potential means overcoming resistance to change. What makes this area so exciting is that it frequently involves people, people with a vision and tenacity to make change.

Being a change agent is timely and important as economies strive to diversify and societies strive to solve entrenched social problems. Success requires  leadership for overcoming entrenched rigidities, barriers to change that serve to sustain the status quo and protect established interests. 

Change is rarely easy, so we are thrilled to share stories about technologies AND people, people as leaders with vision and the courage to confront today for a better tomorrow. 

Some leaders have titles. Most do not. What they share is inspiration. In business we call them "entrepreneurs" - commercializing knowledge. In academia they are called "researchers" - knowledge seekers. Change through technology warrants their collaboration.